SCHEMBL1301030

SCHEMBL1301030

CC=CS(=O)(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5441708 1.00
SCHEMBL1301029 1.00
SCHEMBL28036859 0.84 TSHR (0.30)
SCHEMBL1726616 0.72
SCHEMBL696653 0.69
SCHEMBL1396576 0.67
SCHEMBL9279662 0.67
SCHEMBL1110045 0.67
SCHEMBL5393533 0.67
SCHEMBL10758503 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113444059-B Process for preparing 2- (methylsulfonyl) -oxirane and derivatives thereof 河北圣泰材料股份有限公司 2024-06-04 CN claimed
CN-115975124-A Hyperbranched polyether monomer, hyperbranched EPEG type polycarboxylate superplasticizer and preparation method thereof 科之杰新材料集团有限公司 2023-04-18 CN claimed
CN-114702771-A Method for optimizing dielectric property of potassium tantalate-niobate/polyvinylidene fluoride film by utilizing acyl chloride micromolecules 哈尔滨理工大学 2022-07-05 CN claimed
CN-113444059-A Process for the preparation of 2- (methylsulfonyl) -oxirane and derivatives thereof 石家庄圣泰化工有限公司 2021-09-28 CN claimed
EP-3912979-B1 TYROSINE KINASE INHIBITORS PRINCIPIA BIOPHARMA INC (US) 2026-03-25 EP disclosed
US-20250353854-A1 FUSED PYRIMIDINE COMPOUNDS AS INHIBITORS OF MENIN BIOMEA FUSION INC (US) 2025-11-20 US disclosed
US-20250197402-A1 Tyrosine Kinase Inhibitors PRINCIPIA BIOPHARMA INC. (US) 2025-06-19 US disclosed
EP-3728194-B1 QUINOLINE SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS OTAGO INNOVATION LTD (NZ) 2025-06-04 EP disclosed
US-20250171464-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2025-05-29 US disclosed
US-12275745-B2 Therapeutic compounds and methods of use GENENTECH, INC. (US) 2025-04-15 US disclosed
US-20250074881-A1 THERAPEUTIC COMPOUNDS AND METHODS OF USE GENENTECH, INC. (US) 2025-03-06 US disclosed
US-12110276-B2 Pyrazolo compounds and methods of use thereof GENENTECH, INC. (US) 2024-10-08 US disclosed
US-6177226-B1 PROVIDES A CONTACT HOLE PATTERN IMAGE HAVING LESS DIMPLES AND BEING IN EXACT ACCORDANCE WITH A MASK PATTERN TOKYO OHKA KOGYO CO., LTD. (JP) 2001-01-23 US disclosed
US-6127087-A COMPOSITION COMPRISING ALKALI-SOLUBLE RESIN, SPECIFIED QUINONEDIAZIDE COMPOUND TOKYO OHKA KOGYO CO., LTD. (JP) 2000-10-03 US disclosed
US-6120969-A PHENOLIC RESINS FOR PHOTORESISTS TOKYO OHKA KOGYO CO., LTD. (JP) 2000-09-19 US disclosed
US-5853948-A Positive photoresist compositions and multilayer resist materials using the same TOKYO OHKA KOGYO CO., LTD. (JP) 1998-12-29 US disclosed
US-5728504-A Positive photoresist compositions and multilayer resist materials using the same TOKYO OHKA KOGYO CO., LTD. (JP) 1998-03-17 US disclosed
EP-0510983-B1 Positive resist composition NIPPON ZEON CO (JP) 1996-03-27 EP disclosed
US-5376497-A Good sensitivity, rate of residual film and resolution NIPPON ZEON CO., LTD. (JP) 1994-12-27 US disclosed
EP-0510983-A1 Positive resist composition NIPPON ZEON CO., LTD. (JP) 1992-10-28 EP disclosed